Resources
Download this reportCombating Malaria
Inside this issue
• For rapid diagnosis kits to work prescribing habits need to change
• Partnerships between agencies and pharma companies are boosting hopes - -
Content
Hopes still high that killer can be beaten
The death rate is falling, but chances of eradication are tempered by realities of cost and science, writes Andrew Jack
Diagnostics: Rapid tests come with challenges
Charis Gresser says potential will only be fulfilled if prescribing habits and patient expectations change
Vaccines: Partnerships boost success hopes
The world’s first large-scale clinical trial of a malaria vaccine has just completed enrolment, writes Clive Cookson
Drug efficacy: Rising resistance worries in Cambodia
The problem is also spreading to the Thai-Burma border, a problem hotspot, notes Tim Johnston
Health warning: Ineffective buzzers
The appeal is tempting, but reality is dangerous and potentially lethal, writes Andrew Jack
Senegal: Reliable diagnoses help reduce incidence
Community-based volunteers are helping the fight, says Andrew Jack
ACT production: ‘The biggest challenge is access to the market’
African drugmakers call for more donor help. Katrina Manson reports
Bed nets: Proximity may be the best policy
Production in Africa may help boost economies, writes Sarah Murray
Prophylaxis: Scheme can help mother and child
But there are fears that the costs may outweigh the benefits, reports Jack Serle
Insecticides: Researchers probe creative ways to kill mosquitoes
Clive Cookson stresses that the rapid evolution of resistance highlights the urgent need for replacement compounds
